1-Methyl-4-benzylpiperazine

Drugbox
IUPAC_name = 1-methyl-4-(phenylmethyl)piperazine


width= 140

---

CAS_number= 374898-00-7
ATC_prefix=
ATC_suffix=
PubChem= 763557
DrugBank=
C=12 | H=18 | N=2
molecular_weight = 190.294 g/mol
bioavailability=
metabolism = hepatic
elimination_half-life=
excretion = renal
pregnancy_category =
legal_status =
routes_of_administration= oral

MBZP (1-methyl-4-benzylpiperazine) is a stimulant drug which is a derivative of benzylpiperazine. MBZP has been sold as an ingredient in legal recreational drugs known as "Party pills", initially in New Zealand and subsequently in other countries around the world.

The effects of MBZP are very similar to those of BZP, but the stimulant effect is slightly weaker and it seems to have less of a tendency to cause negative side effects such as headaches and nausea.

Based on the recommendation of the EACD, the New Zealand government has passed legislation which placed BZP, along with the other piperazine derivatives TFMPP, mCPP, pFPP, MeOPP and MBZP, into Class C of the New Zealand Misuse of Drugs Act 1975. A ban was intended to come into effect in New Zealand on December 18th 2007, but the law change did not go through until the following year, and the sale of BZP and the other listed piperazines became illegal in New Zealand as of 1st of April 2008. An amnesty for possession and usage of these drugs will remain until October 2008, at which point they will become completely illegal. [ [http://www.parliament.nz/en-NZ/PB/Legislation/Bills/d/3/d/00DBHOH_BILL8220_1-Misuse-of-Drugs-Classification-of-BZP-Amendment.htm Misuse of Drugs (Classification of BZP) Amendment Bill 2008] ]

References

ee also

*pFPP
*mCPP
*MeOPP
*TFMPP
*MDBZP
*2C-B-BZP
*DBZP
*Piperazine